Our mission is the unique integration of two very compelling goals: to collect excess breast milk from qualified donors for premature infants, and simultaneously give back to the community in a significant and meaningful way by financially supporting selected charities based on the amount of donated milk received.
In the absence of human milk donors, there would not be a way to provide human milk fortifier and standardized human milk processed from 100% human breast milk to babies in need. We appreciate your breast milk donation and want to make the experience as pleasant as possible. Your generous donation is valued highly by the medical community as well as the families with preterm and sick babies.
Along with your valuable breast milk donation, Prolacta Bioscience has pledged to contribute $1 to Susan G. Komen for the Cure in support of breast cancer research for every ounce of qualified milk we collect. This important cause was chosen as recipient of the contribution because studies show a correlation between breastfeeding and a reduction in a woman’s risk of developing breast cancer.1 2 Prolacta supports the strong alignment between breast feeding, breast milk donation and breast cancer research.
1“Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease”, Lancet, Vol 360 No. 9328, pp 187-195
2Alison M. Stuebe; Walter C. Willett; Fei Xue; Karin B. Michels. “Lactation and Incidence of Premenopausal Breast Cancer: A Longitudinal Study.” Arch Intern Med., 2009; 169 (15): 1364-1371
Your valuable donation will contribute $1 per ounce to support Susan G. Komen for the Cure
Prolacta Bioscience has pledged to contribute $1 to the fight against breast cancer for every ounce of qualified milk we collect. Susan G. Komen for the Cure was chosen as the recipient of this contribution because of their admirable work in fighting breast cancer.
Minimum Contribution: $25,000
Program Active: May 1, 2013 – April 30, 2014
Visit Komen Website